Skip to content

Early diagnosis of Kawasaki disease and prediction model of pellet tolerance established based on miRNA

Early diagnosis of Kawasaki disease and prediction model of pellet tolerance established based on miRNA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036888
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Disease

Interventions

Gold Standard:Meet the diagnostic criteria established by the American Heart Association (AHA) in 2017: Fever lasts for 5 days or more, excluding other infectious diseases with similar manifestations
Extremities: Acute hard swelling of hands and feet, and desquamination of toe ends in convalescence
Pleomorphic rash
(4) Bilateral bulbous&#32
miR-125a-5p,&#32

Sponsors

Shanghai Children's Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: KD group: The KD children met the diagnostic criteria established by the American Heart Association (AHA) in 2017: (1) Fever lasts for 5 days or more, excluding other infectious diseases with similar manifestations; (2) Extremities: Acute hard swelling of hands and feet, and desquamination of toe ends in convalescence; (3) Pleomorphic rash; (4) Bilateral bulbous conjunctiva hyperemia without exudative changes; (5) Changes in the lips and mouth: chapped lips, arbutus tongue, mouth and throat mucosal diffuse congestion; Cervical lymph node enlargement (diameter > 1.5 cm), usually on one side; Among them, fever lasting for 5 days or more is the necessary condition, meeting at least 4 of the other 5 criteria, and excluding other diseases, KD can be confirmed.KD can also be diagnosed on day 4 when at least 4 clinical criteria are present. Inclusion criteria for the fever control group: respiratory infectious diseases or other febrile diseases such as scarlet fever, juvenile idiopathic arthritis, etc.

Exclusion criteria

Exclusion criteria: Children with a history of Kawasaki disease were excluded, including cardiovascular diseases and autoimmune diseases

Design outcomes

Primary

MeasureTime frame
miRNA;

Countries

China

Contacts

Public ContactChen Liqin

Shanghai Children's Hospital

416278974@qq.com+86 15800382761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026